Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT05070312
Status:
COMPLETED
Last Update Posted:
2022-03-25
First Post:
2021-07-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese Participants
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-27
First Submit QC Date:
None
Study First Post Date:
2021-10-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-24
Last Update Post Date:
2022-03-25
Last Update Post Date Type:
ACTUAL